China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $163.2M
Liabilities Breakdown FY2012
Total Liabilities: $14.7M
Asset Breakdown
Total Assets: $163.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.0M | 2.5% |
| Accounts Receivable | $66.2M | 40.5% |
| Inventory | $36.4M | 22.3% |
| Property, Plant & Equipment | $9.0M | 5.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $2.4M | 1.5% |
| Other Assets | $45.2M | 27.7% |
Liabilities Breakdown
Total Liabilities: $14.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.8M | 19.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $11.9M | 80.7% |